Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonella typhimurium, and Pseudomonas aeruginosa
LEARN MOREFor vaccination of healthy chickens 6-18 weeks of age by wing-web administration in the prevention of fowl pox.
LEARN MORETriple-action, once-a-day treatment for 7 days for even the most stubborn cases associated with susceptible strains of yeast and bacteria in canines.
LEARN MOREIntranasal vaccine for healthy cattle, 1 week or older against IBR virus, BRSV, PI3, Mannheimia haemolytica and Pasteurella multocida.
LEARN MORE